Tag Archives: Biotech stocks

Biotech and the overall equity markets have been under siege the past few months from macro forces, like oil and the economy, as well as sector-specific concerns like drug pricing. After watching the carnage in 2016 wreck havoc with small

The stock market has been a wild ride of late – big moves up and down, NYSE getting halted, Grexit, China – lots of reasons for added skittishness. The VIX index, which measures the volatility of the S&P500, has gone

Getting high quality analyst coverage of your company as a recently minted IPO is important for communicating the rationale and excitement around your story. Thoughtful analysts can evangelize (or punish) companies they believe in (or not). But understanding the relationship